171 related articles for article (PubMed ID: 11971909)
1. Elimination of P1 arginine 393 interaction with underlying glutamic acid 255 partially activates antithrombin III for thrombin inhibition but not factor Xa inhibition.
Jairajpuri MA; Lu A; Bock SC
J Biol Chem; 2002 Jul; 277(27):24460-5. PubMed ID: 11971909
[TBL] [Abstract][Full Text] [Related]
2. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
[TBL] [Abstract][Full Text] [Related]
3. Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence. Evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin.
Chuang YJ; Swanson R; Raja SM; Olson ST
J Biol Chem; 2001 May; 276(18):14961-71. PubMed ID: 11278930
[TBL] [Abstract][Full Text] [Related]
4. Role of arginine 132 and lysine 133 in heparin binding to and activation of antithrombin.
Meagher JL; Huntington JA; Fan B; Gettins PG
J Biol Chem; 1996 Nov; 271(46):29353-8. PubMed ID: 8910598
[TBL] [Abstract][Full Text] [Related]
5. Localization of an antithrombin exosite that promotes rapid inhibition of factors Xa and IXa dependent on heparin activation of the serpin.
Izaguirre G; Zhang W; Swanson R; Bedsted T; Olson ST
J Biol Chem; 2003 Dec; 278(51):51433-40. PubMed ID: 14532267
[TBL] [Abstract][Full Text] [Related]
6. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement.
Olson ST; Björk I; Sheffer R; Craig PA; Shore JD; Choay J
J Biol Chem; 1992 Jun; 267(18):12528-38. PubMed ID: 1618758
[TBL] [Abstract][Full Text] [Related]
7. Specificity of the basic side chains of Lys114, Lys125, and Arg129 of antithrombin in heparin binding.
Schedin-Weiss S; Arocas V; Bock SC; Olson ST; Björk I
Biochemistry; 2002 Oct; 41(41):12369-76. PubMed ID: 12369826
[TBL] [Abstract][Full Text] [Related]
8. Molecular determinants of the mechanism underlying acceleration of the interaction between antithrombin and factor Xa by heparin pentasaccharide.
Quinsey NS; Whisstock JC; Le Bonniec B; Louvain V; Bottomley SP; Pike RN
J Biol Chem; 2002 May; 277(18):15971-8. PubMed ID: 11854268
[TBL] [Abstract][Full Text] [Related]
9. Residues Tyr253 and Glu255 in strand 3 of beta-sheet C of antithrombin are key determinants of an exosite made accessible by heparin activation to promote rapid inhibition of factors Xa and IXa.
Izaguirre G; Olson ST
J Biol Chem; 2006 May; 281(19):13424-13432. PubMed ID: 16517611
[TBL] [Abstract][Full Text] [Related]
10. Conformational conversion of antithrombin to a fully activated substrate of factor Xa without need for heparin.
Huntington JA; Gettins PG
Biochemistry; 1998 Mar; 37(10):3272-7. PubMed ID: 9521646
[TBL] [Abstract][Full Text] [Related]
11. Dissociation of heparin-dependent thrombin and factor Xa inhibitory activities of antithrombin-III by mutations in the reactive site.
Theunissen HJ; Dijkema R; Grootenhuis PD; Swinkels JC; de Poorter TL; Carati P; Visser A
J Biol Chem; 1993 Apr; 268(12):9035-40. PubMed ID: 8473344
[TBL] [Abstract][Full Text] [Related]
12. The role of the COOH-terminal region of antithrombin III. Evidence that the COOH-terminal region of the inhibitor enhances the reactivity of thrombin and factor Xa with the inhibitor.
Nishioka J; Suzuki K
J Biol Chem; 1992 Nov; 267(31):22224-9. PubMed ID: 1331047
[TBL] [Abstract][Full Text] [Related]
13. Conformational equilibrium of the reactive center loop of antithrombin examined by steady state and time-resolved fluorescence measurements: consequences for the mechanism of factor Xa inhibition by antithrombin-heparin complexes.
Futamura A; Beechem JM; Gettins PG
Biochemistry; 2001 Jun; 40(22):6680-7. PubMed ID: 11380263
[TBL] [Abstract][Full Text] [Related]
14. Substitution of arginine for Leu444 in the reactive site of heparin cofactor II enhances the rate of thrombin inhibition.
Derechin VM; Blinder MA; Tollefsen DM
J Biol Chem; 1990 Apr; 265(10):5623-8. PubMed ID: 2138609
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of heparin activation of antithrombin. Evidence for reactive center loop preinsertion with expulsion upon heparin binding.
Huntington JA; Olson ST; Fan B; Gettins PG
Biochemistry; 1996 Jul; 35(26):8495-503. PubMed ID: 8679610
[TBL] [Abstract][Full Text] [Related]
16. Mutagenesis of thrombin selectively modulates inhibition by serpins heparin cofactor II and antithrombin III. Interaction with the anion-binding exosite determines heparin cofactor II specificity.
Sheehan JP; Wu Q; Tollefsen DM; Sadler JE
J Biol Chem; 1993 Feb; 268(5):3639-45. PubMed ID: 8429040
[TBL] [Abstract][Full Text] [Related]
17. Energetics of hydrogen bond switch, residue burial and cavity analysis reveals molecular basis of improved heparin binding to antithrombin.
Singh P; Singh K; Jairajpuri MA
J Biomol Struct Dyn; 2011 Oct; 29(2):339-50. PubMed ID: 21875153
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms responsible for catalysis of the inhibition of factor Xa or thrombin by antithrombin using a covalent antithrombin-heparin complex.
Paredes N; Wang A; Berry LR; Smith LJ; Stafford AR; Weitz JI; Chan AK
J Biol Chem; 2003 Jun; 278(26):23398-409. PubMed ID: 12695507
[TBL] [Abstract][Full Text] [Related]
19. Identification of the antithrombin III heparin binding site.
Ersdal-Badju E; Lu A; Zuo Y; Picard V; Bock SC
J Biol Chem; 1997 Aug; 272(31):19393-400. PubMed ID: 9235938
[TBL] [Abstract][Full Text] [Related]
20. Lysine residue 114 in human antithrombin III is required for heparin pentasaccharide-mediated activation.
Kridel SJ; Knauer DJ
J Biol Chem; 1997 Mar; 272(12):7656-60. PubMed ID: 9065421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
